Topics
Advanced Reactors
Decontamination and Decommissioning
Education
Enforcement
Environmental Remediation
Fuel
Industry
Isotopes & Radiation
Licensing
Meetings
Nonproliferation
Nuclear History
People
Policy
Power & Operations
Research & Applications
Security
Standards
Supply Chain
Transportation
Waste Management
Webinar
Workforce
Sources
Nuclear News
Radwaste Solutions
ANS News
ANS Nuclear Cafe
Sponsored Content
Press Releases
Sign Up
Buyers Guide
Access Online Buyers Guide
Manage/Create Company Listings
Advertise in Buyers Guides
Advertise
Share an Article
Astatine-211 targets blood-borne cancers in Seattle clinical trials
Your Name
Your Email Address
Recipient's Name
Recipient's Email Address
Message to Recipient
I thought you might be interested in this article.
Send Message
